Find participating medical centers and current study status in each of them

    Find participating medical centers

    A clinical trial to look at how safe and effective atezolizumab plus nab-paclitaxel is for treatment of triple-negative breast cancer (TNBC) that cannot be removed with surgery

    A Study of Atezolizumab (Tecentriq) Plus Nab-Paclitaxel or Paclitaxel in the Treatment of Unresectable Locally Advanced or Metastatic Triple‑Negative Breast Cancer

    • Cancer
    • Breast Cancer
    • Triple Negative Breast Cancer

    For the latest version of this information please go to www.forpatients.roche.com